Literature DB >> 12505689

The quest for a vascular endothelial cannabinoid receptor.

George Kunos1, Sándor Bátkai, László Offertáler, Fanny Mo, Jie Liu, Jan Karcher, Judith Harvey-White.   

Abstract

This review examines pharmacological and biochemical evidence that suggests the existence of an as yet undefined endothelial receptor that mediates endocannabinoid-induced vasodilation. The signaling mechanisms triggered through this receptor and its potential physiological role are also discussed. Since vasodilation is often associated with hypotension, mechanisms involved in the hypotensive actions of cannabinoids, including the endocannabinoids anandamide and 2-arachidonoylglycerol, are also briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505689     DOI: 10.1016/s0009-3084(02)00145-7

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  15 in total

Review 1.  Endocannabinoids and cardiac contractile function: pathophysiological implications.

Authors:  Sándor Bátkai; Pál Pacher
Journal:  Pharmacol Res       Date:  2009-08       Impact factor: 7.658

Review 2.  Stress regulates endocannabinoid-CB1 receptor signaling.

Authors:  Cecilia J Hillard
Journal:  Semin Immunol       Date:  2014-05-29       Impact factor: 11.130

Review 3.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 4.  Implication of cannabinoids in neurological diseases.

Authors:  Angela Alsasua del Valle
Journal:  Cell Mol Neurobiol       Date:  2006-05-12       Impact factor: 5.046

Review 5.  Cardiovascular pharmacology of cannabinoids.

Authors:  P Pacher; S Bátkai; G Kunos
Journal:  Handb Exp Pharmacol       Date:  2005

Review 6.  Blood pressure regulation by endocannabinoids and their receptors.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Neuropharmacology       Date:  2005-02-19       Impact factor: 5.250

7.  Functional disassociation of the central and peripheral fatty acid amide signaling systems.

Authors:  Benjamin F Cravatt; Alan Saghatelian; Edward G Hawkins; Angela B Clement; Michael H Bracey; Aron H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

8.  Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  J Physiol       Date:  2004-04-30       Impact factor: 5.182

Review 9.  The therapeutic potential of novel cannabinoid receptors.

Authors:  Faith R Kreitzer; Nephi Stella
Journal:  Pharmacol Ther       Date:  2009-02-25       Impact factor: 12.310

10.  The endocannabinoid N-arachidonoyl glycine (NAGly) inhibits store-operated Ca2+ entry by preventing STIM1-Orai1 interaction.

Authors:  Andras T Deak; Lukas N Groschner; Muhammad Rizwan Alam; Elisabeth Seles; Alexander I Bondarenko; Wolfgang F Graier; Roland Malli
Journal:  J Cell Sci       Date:  2012-12-13       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.